Trending Topic

3D rendered Medical Illustration of Male Anatomy - Rectal Cancer.
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriel Valagni, Nkafu Bechem Ndemazie, Tiago Biachi de Castria

Trifluridine/tipiracil (FTD/TPI) is a novel oral formulation of two drugs with promising results in the treatment of metastatic colorectal cancer (mCRC).1 Trifluridine is a thymidine-based nucleoside analogue that, after intracellular phosphorylation, gets incorporated into DNA, causing DNA dysfunction.2 It was first identified by Callahan et al. in 1996 as an active impurity in the herbicide trifluralin, which […]

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: May 26th 2021

Co-Chair of the European Cancer Organisation’s Impact of COVID-19 on Cancer Special Network, Prof. Mark Lawler (Queen’s University, Belfast, UK) speaks to touchONCOLOGY about the impact the COVID-19 pandemic has had on cancer care and the newly launched ‘Time to Act’ campaign. Further information about the campaign can be found on the European Cancer Organisation’s website at https://www.europeancancer.org/timetoact.

Questions

  1. How has the COVID-19 pandemic impacted on cancer care across Europe? (0:18)
  2. Could you tell us a little about the ‘Time to Act’ campaign and its objectives? (1:04)
  3. What advice has the European Cancer Organisation given to governments? (2:24)
  4. What are the major obstacles to addressing the current unmet needs in cancer care and how can they be overcome? (3:02)

Disclosures: Unrestricted educational grant from Pfizer for research unrelated to this work. Honoraria from Pfizer, EMD Serono , Roche and Carnall Farrar unrelated to this work.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Helen Fowler.

 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup